Blog

Immunotherapy Prolongs Hepatocellular Carcinoma Survival – Medscape


Medscape

Immunotherapy Prolongs Hepatocellular Carcinoma Survival
Medscape
Immunotherapy Prolongs Hepatocellular Carcinoma Survival. Neil Osterweil. April 18, 2018. PARIS — For patients with hepatocellular carcinoma, adjuvant immunotherapy with autologous cytokine-induced killer cells significantly extends 5-year recurrence

2018-04-18 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.